Insider Trading Alert - CCRN, CNSL And TSLX Traded By Insiders

Yesterday, Nov. 30, 2015, 79 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $97.50 to $4,584,763.71.

Highlighted Stocks Traded by Insiders:

Cross Country Healthcare (CCRN) - FREE Research Report

Ball Susan E, who is General Counsel & Secretary at Cross Country Healthcare, sold 40,000 shares at $18.00 on Nov. 30, 2015. Following this transaction, the General Counsel & Secretary owned 93,469 shares meaning that the stake was reduced by 29.97% with the 40,000-share transaction.

The shares most recently traded at $17.46, down $0.54, or 3.09% since the insider transaction. Historical insider transactions for Cross Country Healthcare go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 3,000
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 3,000
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 3,000

The average volume for Cross Country Healthcare has been 436,600 shares per day over the past 30 days. Cross Country Healthcare has a market cap of $589.9 million and is part of the services sector and diversified services industry. Shares are up 46.23% year-to-date as of the close of trading on Monday.

Cross Country Healthcare, Inc. provides healthcare staffing and workforce solutions in the United States. The company operates through three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. Currently, there are 4 analysts who rate Cross Country Healthcare a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CCRN - FREE

TheStreet Quant Ratings rates Cross Country Healthcare as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Cross Country Healthcare Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Consolidated Communications (CNSL) - FREE Research Report

Childers Steven L, who is Chief Financial Officer at Consolidated Communications, sold 2,500 shares at $22.00 on Nov. 30, 2015. Following this transaction, the Chief Financial Officer owned 87,616 shares meaning that the stake was reduced by 2.77% with the 2,500-share transaction.

The shares most recently traded at $21.87, down $0.13, or 0.59% since the insider transaction. Historical insider transactions for Consolidated Communications go as follows:

  • 4-Week # shares sold: 11,000
  • 12-Week # shares sold: 11,000
  • 24-Week # shares sold: 11,000

The average volume for Consolidated Communications has been 187,700 shares per day over the past 30 days. Consolidated Communications has a market cap of $1.1 billion and is part of the technology sector and telecommunications industry. Shares are down 21.7% year-to-date as of the close of trading on Monday.

Consolidated Communications Holdings, Inc., through its subsidiaries, provides various integrated communications services to residential and business clients. The stock currently has a dividend yield of 7.03%. Currently, there are 2 analysts who rate Consolidated Communications a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CNSL - FREE

TheStreet Quant Ratings rates Consolidated Communications as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. Get the full Consolidated Communications Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TPG Specialty Lending (TSLX) - FREE Research Report

Tanemura Ronald, who is Director at TPG Specialty Lending, bought 200 shares at $17.00 on Nov. 30, 2015. Following this transaction, the Director owned 31,291 shares meaning that the stake was boosted by 0.64% with the 200-share transaction.

The shares most recently traded at $17.35, up $0.35, or 2.02% since the insider transaction. Historical insider transactions for TPG Specialty Lending go as follows:

  • 4-Week # shares bought: 30,257
  • 4-Week # shares sold: 2.6 million
  • 12-Week # shares bought: 30,257
  • 12-Week # shares sold: 2.6 million
  • 24-Week # shares bought: 30,257
  • 24-Week # shares sold: 2.6 million

The average volume for TPG Specialty Lending has been 119,700 shares per day over the past 30 days. TPG Specialty Lending has a market cap of $936.0 million and is part of the financial sector and real estate industry. Shares are up 2.32% year-to-date as of the close of trading on Monday.

TPG Specialty Lending, Inc. is a business development company. The stock currently has a dividend yield of 9.03%. The company has a P/E ratio of 9.8. Currently, there are 4 analysts who rate TPG Specialty Lending a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TSLX - FREE

TheStreet Quant Ratings rates TPG Specialty Lending as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins and good cash flow from operations. However, as a counter to these strengths, we find that the growth in the company's net income has been quite unimpressive. Get the full TPG Specialty Lending Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Global Stocks Hit by Asia Tech Weakness, Oil Price Rally; U.S. Futures Slip

Global Stocks Hit by Asia Tech Weakness, Oil Price Rally; U.S. Futures Slip

Skechers Slumps in Pre-Market After Soft Guidance Overshadows Solid Q1

Skechers Slumps in Pre-Market After Soft Guidance Overshadows Solid Q1

Ericsson Rockets After Solid Q1 Following Cevian Push to Accelerate Turnaround

Ericsson Rockets After Solid Q1 Following Cevian Push to Accelerate Turnaround

P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI

P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Is Best Buy Sleeping With the Enemy With Amazon Partnership?